Several genes conferring susceptibility to breast and ovarian cancer, notably BRCA1 and BRCA2, have been identified. The majority of the familial aggregation of breast cancer is, however, not ...
SAN FRANCISCO, Jan. 22, 2026 /PRNewswire/ -- Allelica, a precision medicine company focused on genomic risk assessment for common diseases, today announced that it has entered into a commercial ...
Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm (BOADICEA v7) predicts future breast cancer (BC) risk using data on cancer family history (FH), genetic markers, ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Boadicea Resources Ltd. ( (AU:BOA)) just ...
Areas of Uncertainty in Pancreatic Cancer Surveillance: A Survey Across the International Pancreatic Cancer Early Detection (PRECEDE) Consortium Breast and Ovarian Analysis of Disease Incidence and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results